Expertise in
53
conditions

Dr. Phillip J. Goldstein

Internal Medicine
Carolina Digestive LLC
704 Wh Smith Blvd, 
Greenville, NC 
Accepting New Patients
Offers Telehealth
Expertise in
53
conditions
Carolina Digestive LLC
704 Wh Smith Blvd, 
Greenville, NC 

Overview

Phillip Goldstein is a primary care provider, practicing in Internal Medicine in Greenville, North Carolina.

Dr. Goldstein is highly rated in 53 conditions, according to our data. His clinical expertise encompasses Gastroesophageal Reflux Disease (GERD), Gastric Dysmotility, Gastroparesis, and Juvenile Polyposis Syndrome.

He is actively involved in clinical research, participating in 10 clinical trials. Dr. Goldstein is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in NY

Hospital Affiliations

Ecu Health Medical Center
Vidant Roanoke Chowan Hospital
Vidant Chowan Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
AmeriHealth
  • EPO
  • HMO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
FirstCarolinaCare
  • HMO
  • MEDICARE MAPD
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 21 Less Insurance Carriers -

Locations

Carolina Digestive LLC
704 Wh Smith Blvd, Greenville, NC 27834

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 11, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: May 13, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
Enrollment Status: Completed
Publish Date: August 30, 2022
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602K in Patients With NASH (EMMINENCE™)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602K in Patients With NASH (EMMINENCE™)
Enrollment Status: Completed
Publish Date: September 16, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials
Similar Doctors
Expertise in
17
conditions
Dr. Ghiath M. Almasri
Internal Medicine
Expertise in
17
conditions
Dr. Ghiath M. Almasri
Internal Medicine

ECU Health Medical Center

2100 Stantonsburg Rd, 
Greenville, NC 
 (0.3 miles away)
252-847-4157
Languages Spoken:
English
See accepted insurances

Ghiath Almasri is a primary care provider, practicing in Internal Medicine in Greenville, North Carolina. Dr. Almasri is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Heart Attack, Apoplexy, Necrosis, Pacemaker Implantation, and Cardiac Ablation.

Expertise in
11
conditions
Dr. Paul R. Walker
Internal Medicine
Expertise in
11
conditions
Dr. Paul R. Walker
Internal Medicine

Leo W Jenkins Cancer Center

600 Moye Blvd # 3-E, 
Greenville, NC 
 (4.0 miles away)
252-744-1888
Languages Spoken:
English
See accepted insurances

Paul Walker is a primary care provider, practicing in Internal Medicine in Greenville, North Carolina. Dr. Walker is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Gamma Knife Radiosurgery, and Advanced Bronchoscopy.

Expertise in
11
conditions
Dr. Leonard B. Johnson
Internal Medicine
Expertise in
11
conditions
Dr. Leonard B. Johnson
Internal Medicine

ECU Health Medical Center

2100 Stantonsburg Rd, 
Greenville, NC 
 (0.3 miles away)
252-847-4100
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Leonard Johnson is a primary care provider, practicing in Internal Medicine in Greenville, North Carolina. He has been practicing medicine for over 17 years. Dr. Johnson is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Sepsis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Urinary Tract Infection (UTI), Hip Replacement, and Endoscopy. Dr. Johnson is currently accepting new patients.

Frequently Asked Questions about Dr. Phillip J. Goldstein

How do I make an appointment with Dr. Phillip J. Goldstein?

You can book an appointment with Dr. Phillip J. Goldstein by calling their office at 252-758-8181. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Phillip J. Goldstein a top-rated expert for Gastroesophageal Reflux Disease (GERD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Phillip J. Goldstein is classified as an Distinguished expert for Gastroesophageal Reflux Disease (GERD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Phillip J. Goldstein specialize in?

While Dr. Phillip J. Goldstein is a Internal Medicine, they have specific expertise in Gastroesophageal Reflux Disease (GERD), Gastric Dysmotility, and Gastroparesis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Phillip J. Goldstein accept my insurance?

Dr. Phillip J. Goldstein accepts most major insurance plans, including Aetna and AmeriHealth. We recommend calling the office directly at 252-758-8181 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Goldstein's expertise for a condition
ConditionClose
    View All 22 Distinguished Conditions
    View All 31 Advanced Conditions
    View All 54 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile